Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples

NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board

This public procurement record has 1 release in its history.

Award

12 May 2021 at 16:34

Summary of the contracting process

The procurement process is being conducted by the NHS Wales Shared Services Partnership on behalf of the Cardiff and Vale University Local Health Board for the acquisition of a Next Generation Sequencing Panel intended for the analysis of somatic samples in the healthcare sector. This tender, classified under the CPV code for laboratory reagents, is currently in the Award stage, following its initial tender initiation in March 2021. The process concluded with a contract awarded to Illumina Cambridge Ltd, valued at £10,768,696.40, with significant delivery requirements specified for the All Wales Medical Genomics Laboratory located in Cardiff, UK.

This procurement presents substantial growth opportunities for businesses specialising in laboratory reagents and genomic technology solutions. Companies with expertise in developing and supplying advanced sequencing platforms, particularly those capable of handling both DNA and RNA workflows, would be well-positioned to compete in this market. The ongoing advancement in genomic testing necessitates suppliers who can align their products with clinical requirements, and therefore, firms focusing on innovative biotechnology and healthcare solutions should take note of such tender announcements.

How relevant is this notice?

Notice Title

Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples

Notice Description

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) on behalf of Cardiff and Vale University Health Board are looking to procurement a somatic NGS testing platform with a single workflow for both DNA and RNA library preparation. It must be a targeted panel of at least 500 genes for the DNA component and 50 genes for the RNA component which are of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).

Lot Information

Lot 1

The All Wales Medical Genomics Laboratory (AWMGL) recently received an uplift in funding to enable the delivery of equitable testing for patients in Wales to patients in England who are eligible for tests detailed in the Genomics England National Genomics Test Directory for Cancer, thus, supporting AWMGL to work with Welsh clinicians to align services to the Test Directory. To enable successful alignment it is essential that the laboratory expands their services that are offered to those that are indicated as essential services in the Genomics England National Genomics Test Directory for Cancer 2020/2021 (https://www.england.nhs.uk/publication/national-genomic-test-directories/). To meet the service needs, AWMGL are looking to purchase a new DNA and RNA based single targeted somatic testing panel of at least 500 genes of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02b04b
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/010458-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33696500 - Laboratory reagents

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£10,768,696 £10M-£100M

Notice Dates

Publication Date
12 May 20215 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
16 Mar 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF14 4TT
Postcode Area
Cardiff
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL22 Cardiff and Vale of Glamorgan

Local Authority
Cardiff
Electoral Ward
Heath
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

Illumina Cambridge Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...